反応式
[CH2:1]([C:3]1[CH:4]=[CH:5][CH:6]=[C:7]2[C:11]=1[NH:10][CH:9]=[C:8]2[CH2:12][CH2:13][OH:14])[CH3:2].N1C2C(=CC=CC=2)C(CCO)=C1.[C:27]([CH2:32][C:33]([O:35][CH2:36][CH3:37])=[O:34])(=O)[CH:28]([CH3:30])[CH3:29]>>[CH2:36]([O:35][C:33](=[O:34])[CH2:32][C:27]1([CH:28]([CH3:30])[CH3:29])[C:9]2[NH:10][C:11]3[C:7]([C:8]=2[CH2:12][CH2:13][O:14]1)=[CH:6][CH:5]=[CH:4][C:3]=3[CH2:1][CH3:2])[CH3:37]参加物
4
実験手順
Following the procedure of example 22.A. except using 2-(7-ethyl-1H-indol-3-yl)-ethanol as the 3-indolethanol component and ethyl iso-butyrylacetate as ketone component afforded the title compound as a solid. 1H NMR (500 MHz, CDCl3) δ 9.12 (br, 1H), 7.36 (d, 1H), 7.07 (m, 2H), 4.13 (m, 3H), 3.81 (m, 1H), 3.04 (q, 2H), 2.87 (m, 3H), 2.66 (m, 1H), 2.56 (m, 1H), 1.37 (t, 3H), 1.25 (t, 3H), 1.05 (d, 3H), 0.69 (d, 3H).
出典と根拠
- ORDレコード
- ord-0e1bcedb53d542d094aece03731cfaf6
- 出典データセット
- uspto-grants-2008_01
- 特許番号
- US07314886B2
関連ノート
読み込み中…